2 million doses of J&J vaccine in South Africa possibly contaminated russiaherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from russiaherald.com Daily Mail and Mail on Sunday newspapers.
About one in 10 of the more than 7 million people living with HIV in South Africa are not aware that they have the virus. One way to ensure that more people are diagnosed quicker is to make HIV self-testing kits more widely available – particularly to people who may not otherwise opt to have an HIV test done at a facility.
The World Health Organisation (WHO) defines HIV self-testing as the process whereby an individual collects their own specimen (blood or oral fluid), performs HIV testing using an HIV rapid diagnostic test and interprets the result themselves, either assisted or unassisted.
According to professor Francois Venter, deputy executive director of the Wits Reproductive Health and HIV Institute, and director of Ezintsha – a group of South African academics and health professionals – each test is packaged with a set of easy-to-use instructions which dictate the step-by-step process that needs to be followed to obtain an accurate result.
Simnikiwe Hlatshaneni Medicines body maintains the quality of trials on the efficacy of Ivermectin in Covid‐19 patients is poor and underpowered. People demonstrate to allow the use of Ivermectin for treating Covid-19 patients on 11 January 2021 in Durban. Picture: Gallo Images/Darren Stewart A recently published review of scientific evidence supporting the efficacy of Ivermectin in treating Covid-19 has failed to sway the South African Health Products Authority s position on allowing the use of the drug locally. Ivermectin is a drug used for treatment of parasitic nematode worms, mites and insects in livestock. It is also used to treat parasitic infections in domestic animals and onchocerciasis (river blindness caused by infection with the parasitic worm Onchocerca volvulus) in humans. Previously the health consu
There is still no word on when a safety audit by the US Food and Drug Administration will be complete a requirement before the Johnson & Johnson vaccines that were compounded and finished at the Gqeberha-based plant of Aspen Pharmacare can be released into South Africa’s vaccination programme.
South Africa is relying on the delivery of 31 million doses of the single-shot vaccine for its rollout plans. The vaccine has been approved for use by the South African Health Products Regulatory Authority (SAHPRA), with an advisory issued for pregnant and lactating women.
The only other Covid-19 vaccine approved for use in South Africa, and procured by the government is the one made by Pfizer. South Africa has managed to get 30 million doses of this vaccine, but since it requires two shots, there will only be enough for 15 million people.